INFOSCUM.COM
As IPO nears, J&J eyes $40B valuation for consumer health unit - FiercePharma
Published Date:
4/24/2023
Source:
news.google.com
As IPO nears, J&J eyes $40B valuation for consumer health unit
FiercePharma
Johnson & Johnson consumer health unit valued at $40 billion ahead of IPO, report says
CNBC
J&J's Kenvue consumer health spinoff sets IPO terms
Seeking Alpha
J&J aims for up to $43 bln valuation for consumer health unit Kenvue
Reuters
Johnson & Johnson to price shares of consumer spinoff Kenvue at $20 to $23 in IPO
CNBC
View Full Coverage on Google News
Read the Full Story Here
InfoScum.com